Werewolf Therapeutics (HOWL) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.47
-0.4
-0.34
-0.27

Details

Expected EPS
-0.27
Actual EPS
-0.28
Surprise EPS
-0.01
Surprise Percent
-3.7%

Description

⁨Werewolf Therapeutics⁩ (⁦HOWL⁩) has reported earnings of ⁦-0.28⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts